Literature DB >> 11605789

Methylprednisolone pulse therapy in Japanese children with severe lupus nephritis.

H Tanaka1, T Tateyama, S Waga.   

Abstract

Six Japanese children with severe lupus nephritis received prompt initiation of methylprednisolone pulse therapy (MPT). After three courses of MPT, oral prednisolone combined with a 12-week course of oral cyclophosphamide was given and prednisolone was tapered. At presentation, urine protein excretion and histological indices of the mean activity index and the mean chronicity index in the patients were 2.2 +/- 1.5 g/day, 10.3 +/- 2.0, and 2.8 +/- 1.2, respectively. Urine protein excretion and the activity index decreased significantly at the second renal biopsies obtained at a mean interval of 8 months after the first [0.1 +/- 0.1 g/day and 3.5 +/- 1.4 (P<0.05), respectively], while the chronicity index did not change. At the latest observation (mean interval 53 months), all showed clinical and serological improvement. Complete remission was achieved in two patients, and no patient showed renal impairment. Although this case series is without controls, our treatment protocol may be of benefit to Japanese children with severe lupus nephritis.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11605789     DOI: 10.1007/s004670100640

Source DB:  PubMed          Journal:  Pediatr Nephrol        ISSN: 0931-041X            Impact factor:   3.714


  7 in total

1.  Evaluation of activity, chronicity and tubulointerstitial indices for childhood lupus nephritis.

Authors:  Michael Zappitelli; Ciarán M Duffy; Chantal Bernard; Indra R Gupta
Journal:  Pediatr Nephrol       Date:  2007-10-24       Impact factor: 3.714

2.  Long-term mizoribine intermittent pulse therapy for young patients with flare of lupus nephritis.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Koichi Suzuki; Tohru Nakahata; Etsuro Ito
Journal:  Pediatr Nephrol       Date:  2006-05-24       Impact factor: 3.714

3.  Cyclophosphamide therapy for lupus nephritis: poor renal survival in Arab children.

Authors:  Abdullah A Al Salloum
Journal:  Pediatr Nephrol       Date:  2003-03-28       Impact factor: 3.714

Review 4.  Treatment of pediatric-onset lupus nephritis: a proposal of optimal therapy.

Authors:  Hiroshi Tanaka; Kensuke Joh; Tadaatsu Imaizumi
Journal:  Clin Exp Nephrol       Date:  2017-03-03       Impact factor: 2.801

5.  Practice patterns and approach to kidney biopsy in lupus: a collaboration of the Midwest Pediatric Nephrology Consortium and the Childhood Arthritis and Rheumatology Research Alliance.

Authors:  Scott E Wenderfer; Jerome C Lane; Ibrahim F Shatat; Emily von Scheven; Natasha M Ruth
Journal:  Pediatr Rheumatol Online J       Date:  2015-06-19       Impact factor: 3.054

6.  Tacrolimus monotherapy in a patient with lupus flare using once-daily administration protocol.

Authors:  Hiroshi Tanaka; Kazushi Tsuruga; Shojiro Watanabe; Tomomi Aizawa-Yashiro; Nao Chiba-Fukada; Etsuro Ito
Journal:  NDT Plus       Date:  2011-10

7.  Mizoribine intermittent pulse protocol for induction therapy for systemic lupus erythematosus in children: an open-label pilot study with five newly diagnosed patients.

Authors:  Hiroshi Tanaka; Koji Tsugawa; Eishin Oki; Koichi Suzuki; Etsuro Ito
Journal:  Clin Rheumatol       Date:  2007-05-05       Impact factor: 3.650

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.